NCT07582562

Brief Summary

The goal of this observational study is to identify the risk factors for post-thyroidectomy hypoparathyroidism in Estonia and to determine whether the magnesium level plays a significant role in the development of hypoparathyroidism. The main questions it aims to answer are:

  • How common is post-thyroidectomy hypoparathyroidism in Estonia?
  • What are the most significant risk factors for the development of post-thyroidectomy hypoparathyroidism in Estonia?
  • Are magnesium levels a risk factor for the development of hypoparathyroidism? Participants will be asked to answer a questionnaire about risk factors. The study collects data on risk factors for hypoparathyroidism following thyroid surgery, including patient questionnaires and comorbidities, pre- and postoperative laboratory tests and surgery-related risk factors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Oct 2025

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Oct 2025Dec 2028

Study Start

First participant enrolled

October 13, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

May 13, 2026

Status Verified

May 1, 2026

Enrollment Period

1.8 years

First QC Date

April 21, 2026

Last Update Submit

May 5, 2026

Conditions

Keywords

thyroidectomyhypoparathyroidismrisk factors

Outcome Measures

Primary Outcomes (1)

  • postoperative early hypoparathyroidism

    Incidence of early post-thyroidectomy hypoparathyroidism, based on serum PTH levels measured on the morning of the first postoperative day

    first postoperative day

Secondary Outcomes (3)

  • Risk factor assessment of post-thyroidectomy hypoparathyroidism

    Preoperative and intraoperative periods

  • Serum magnesium levels as predictors of post-thyroidectomy hypoparathyroidism

    Preoperative (baseline) and postoperative day 1; hypoparathyroidism assessed within 24 hours postoperatively

  • Postoperative permanent hypoparathyroidism

    12 months after surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over the age of 18 at Tartu University Hospital and East Tallinn Central Hospital who are undergoing surgery involving both lobes of the thyroid gland (thyroidectomy, "near-total" thyroidectomy, subtotal thyroidectomy, and "completed" thyroidectomy), and who provide informed consent for this.

You may qualify if:

  • patients over the age of 18 undergoing surgery involving both lobes of the thyroid gland (thyroidectomy, "near-total" thyroidectomy, subtotal thyroidectomy, and "completed" thyroidectomy)
  • patients who are capable of giving informed consent

You may not qualify if:

  • patients undergoing unilateral thyroid lobectomy only
  • patients with concomitant hyperparathyroidism undergoing simultaneous thyroidectomy and parathyroidectomy for a parathyroid adenoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

East Tallinn Central Hospital

Tallinn, Estonia

RECRUITING

Tartu University Hospital

Tartu, Estonia

RECRUITING

MeSH Terms

Conditions

Hypoparathyroidism

Condition Hierarchy (Ancestors)

Parathyroid DiseasesEndocrine System Diseases

Central Study Contacts

Hanna Hollman, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
general surgeon, PhD

Study Record Dates

First Submitted

April 21, 2026

First Posted

May 13, 2026

Study Start

October 13, 2025

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

May 13, 2026

Record last verified: 2026-05

Locations